Understanding how embryos establish their own placenta and maintain pluripotent cells
Signaling-regulated establishment of pluripotency in vivo
This study looks at how early mammal embryos, like those in mice, develop their placenta and keep some cells flexible for future growth, helping us understand the important signals and factors involved in this process, which could also relate to how human embryos develop.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10854986 on NIH RePORTER |
What this research studies
This research investigates the critical processes that occur in mammalian embryos during the early stages of development, particularly focusing on how embryos establish their placenta while also reserving some cells to remain pluripotent. The study examines the role of specific signaling pathways and transcription factors, such as SOX2, in determining cell fate at the 16-cell stage of embryonic development. By using mouse models, the research aims to uncover the molecular mechanisms that govern these processes, which may also be relevant to human development.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals undergoing fertility treatments or those interested in developmental biology.
Not a fit: Patients with established pregnancies or those not seeking fertility assistance may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of early human development and improve strategies for regenerative medicine and fertility treatments.
How similar studies have performed: Previous research has successfully identified key mechanisms in embryonic development, suggesting that this approach may yield valuable insights.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Ralston, Amy — Michigan State University
- Study coordinator: Ralston, Amy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.